We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Charles River (CRAI) Announces Name of New VP in Oakland
Read MoreHide Full Article
Charles River Associates (CRAI - Free Report) yesterday announced the appointment of Elizabeth Bailey as a vice president in its Antitrust & Competition Economics Practice in its Oakland, CA office.
Bailey is known for excellence in antitrust, competition policy and intellectual property issues. She has provided economic analysis on mergers and acquisitions in the United States, Canada and Europe. She has appeared before the U.S. Department of Justice, the U.S. Federal Trade Commission and the Canadian Competition Bureau regarding numerous transactions.
She is also a frequent speaker and writer on antitrust and intellectual property. Her papers have been published in The American Economic Review, The Journal of Economic Perspectives, Review of Industrial Organization, The B.E. Journal of Economic Analysis & Policy, and Managing Intellectual Property. She serves as a senior editor for The Antitrust Law Journal, a publication of the American Bar Association’s Section of Antitrust Law. She also serves as a board member for W@Competition in the Americas.
Considering Bailey’s vast experience, the latest appointment is expected to enhance Charles River’s competitive position in Oakland.
CRA’s president and chief executive officer, Paul Maleh, stated, "We’re pleased to welcome Dr. Bailey to our team. She will greatly add to CRA’s team of skilled antitrust experts."
CRA’s Antitrust & Competition Economics Practice leader, Margaret Sanderson, stated, "Dr. Bailey is a highly-sought economic expert for merger analysis, antitrust and intellectual property matters, so we are excited to have her join our team."
Over the past year, shares of Charles River have gained 49.5%, outperforming the 43.9% growth of the industry it belongs to.
Avis Budget has an expected earnings growth rate of 420.6% for the current year. The company has a trailing four-quarter earnings surprise of 76.9%, on average.
Avis Budget’s shares have surged 744.3% in the past year. The company has a long-term earnings growth of 19.4%.
Cross Country Healthcare has an expected earnings growth rate of 447.8% for the current year. The company has a trailing four-quarter earnings surprise of 75%, on average.
Cross Country Healthcare’s shares have surged 201% in the past year. The company has a long-term earnings growth of 21.5%.
Accenture has an expected earnings growth rate of 19.7% for the current year. The company has a trailing four-quarter earnings surprise of 5.3%, on average.
Accenture’s shares have surged 43.2% in the past year. The company has a long-term earnings growth of 10%.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Charles River (CRAI) Announces Name of New VP in Oakland
Charles River Associates (CRAI - Free Report) yesterday announced the appointment of Elizabeth Bailey as a vice president in its Antitrust & Competition Economics Practice in its Oakland, CA office.
Bailey is known for excellence in antitrust, competition policy and intellectual property issues. She has provided economic analysis on mergers and acquisitions in the United States, Canada and Europe. She has appeared before the U.S. Department of Justice, the U.S. Federal Trade Commission and the Canadian Competition Bureau regarding numerous transactions.
She is also a frequent speaker and writer on antitrust and intellectual property. Her papers have been published in The American Economic Review, The Journal of Economic Perspectives, Review of Industrial Organization, The B.E. Journal of Economic Analysis & Policy, and Managing Intellectual Property. She serves as a senior editor for The Antitrust Law Journal, a publication of the American Bar Association’s Section of Antitrust Law. She also serves as a board member for W@Competition in the Americas.
Considering Bailey’s vast experience, the latest appointment is expected to enhance Charles River’s competitive position in Oakland.
CRA’s president and chief executive officer, Paul Maleh, stated, "We’re pleased to welcome Dr. Bailey to our team. She will greatly add to CRA’s team of skilled antitrust experts."
CRA’s Antitrust & Competition Economics Practice leader, Margaret Sanderson, stated, "Dr. Bailey is a highly-sought economic expert for merger analysis, antitrust and intellectual property matters, so we are excited to have her join our team."
Over the past year, shares of Charles River have gained 49.5%, outperforming the 43.9% growth of the industry it belongs to.
Zacks Rank and Stocks to Consider
Charles River currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Business Services sector are Avis Budget (CAR - Free Report) , Cross Country Healthcare (CCRN - Free Report) ) and Accenture (ACN - Free Report) ), each sporting a Zacks Rank #1.
Avis Budget has an expected earnings growth rate of 420.6% for the current year. The company has a trailing four-quarter earnings surprise of 76.9%, on average.
Avis Budget’s shares have surged 744.3% in the past year. The company has a long-term earnings growth of 19.4%.
Cross Country Healthcare has an expected earnings growth rate of 447.8% for the current year. The company has a trailing four-quarter earnings surprise of 75%, on average.
Cross Country Healthcare’s shares have surged 201% in the past year. The company has a long-term earnings growth of 21.5%.
Accenture has an expected earnings growth rate of 19.7% for the current year. The company has a trailing four-quarter earnings surprise of 5.3%, on average.
Accenture’s shares have surged 43.2% in the past year. The company has a long-term earnings growth of 10%.